Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it closed its purchase of soft-tissue microwave ablation system maker NeuWave Medical for an undisclosed amount. NeuWave Medical’s ablation technology was developed at the University of Wisconson, Ethicon said. The company’s Certus 140 ablation system allows for single or simultaneous multiple probe procedures in patients with soft tissue lesions. “Currently, there are […]
Oncology
RefleXion closes $46m Series B
California-based medtech group RefleXion Medical said today it closed a $46 million Series B round of financing, with funds slated to expand its engineering, regulatory and commercial organizations. RefleXion Medical said it is developing a biology-guided radiotherapy system for cancer treatment, which is designed to use positron emission tomography to locate and identify tumors during […]
IsoRay spikes GliaSite radiation therapy device
IsoRay (NYSE:ISR) said yesterday that it’s spiking its GliaSite radiation therapy system for treating brain cancers, after achieving only modest sales since the FDA cleared the device in 2011. Richland, Wash.-based IsoRay said it’s cancelling its deals with Dr. Reddy’s Laboratories (NYSE:RDY), Hologic (NSDQ:HOLX) and Karlheinz Goehl-Medizintechnik Goehl concerning GliaSite. “The GliaSite product has resulted in only marginal […]
EmboMedics raises $4.3m for embolization microbeads
EmboMedics said it raised a $4.3 million Series A1 round for the bioresorbable embolization microspheres it’s developing. Maple Grove, Minn.-based EmboMedics said it plans to use the proceeds to pursue pre-market approval for a drug-delivery device, co-founder & CEO Omid Souresrafil said in prepared remarks. The infusion is enough to carry the company through 2018, Souresrafil said. […]
Edap looks to raise $11m in direct placement round
Edap (NSDQ:EDAP) said today it inked an agreement with institutional investors for the placement of 3.3 million shares at $3.50 a piece, bringing in an estimated $11.5 million for the company. Investors in the round will receive warrants to purchase up to 3.3 million shares at an exercise price of $4.50 per share, exchangeable beginning 6 […]
Edap seeks FDA nod for Focal One HIFU
Edap (NSDQ:EDAP) said today it submitted an application for FDA 510(k) clearance for its next-gen high-intensity focused ultrasound Focal One device designed to treat prostate cancer. The company said the new submission comes following the FDA 510(k) clearance of its Ablatherm Robotic HIFU designed for the ablation of prostate tissue, which it won last November. “We […]
Navidea to seek rheumatoid arthritis indication for Lymphoseek
Navidea (NYSE:NAVB) said today it is beginning the clinical trial development process as it seeks an indication for its Lymphoseek injection for treating rheumatoid arthritis and other disease states. The decision came after a recent meeting with the FDA, the Dublin, Ohio-based company said. “Our efforts to continue to unlock the significant value of the Manocept platform […]
Sirtex slides on sales veep’s exit
SirTex Medical saw share prices fall as much as 7.2% to trade at $21.36 (AUD $28.10), the lowest it’s been in 9 months, after announcing today that its Americas prez Mike Mangano is set to leave at the end of the financial year. SirTex stock has lost 24.4% this year as of Thursday’s close, and […]
John Grisham book turns spotlight on futuristic cancer treatment
(Reuters) – A new book by bestselling author John Grisham is giving new impetus to a handful of companies striving to develop what they say could be a trailblazing treatment for cancer and Alzheimer’s disease. “The Tumor” is a fictional account of a 35-year-old man with brain cancer who, a decade into the future, is […]
Ethicon snags NeuWave Medical
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it is buying soft tissue microwave ablation system producer NeuWave Medical for an undisclosed amount. NeuWave Medical’s ablation technology was developed at the University of Wisconson, Ethicon said. The company’s Certus 140 ablation system allows for single or simultaneous multiple probe procedures in patients with soft tissue lesions. […]
Novocure wins reimbursement from Humana for Optune brain cancer device
NovoCure (NSDQ:NVCR) said today it won reimbursement from Humana for treatments with its Optune device for patients with recurrent glioblastoma. The Optune is a mobile device that delivers low-intensity, intermediate frequency, alternating electric fields, referred to as “tumor treating fields,” to inhibit cancer cell replication and cause cancer cell death. The new reimbursement win brings the […]